Literature DB >> 12857965

Mechanisms, manifestations, and failures of self-tolerance.

Andrew J Caton1.   

Abstract

We have developed transgenic (Tg) mice that express the influenza virus A/PR/8/34 hemagglutinin (PR8 HA) as a well-characterized model antigen with which to analyze factors governing tolerance and autoreactivity among CD4+ T and B cells. To analyze how the expression of self-antigens in varying amounts and in different cell types and tissues affects these processes, we have used a variety of promoters and enhancers to drive HA expression. By mating these HA Tg mice with Tg mice-expressing HA-specific major histocompatibility complex (MHC) class II-restricted T cell receptors (TCRs), we have shown that variations in the expression of the HA in different HA Tg lineages can cause CD4+ T cells with identical specificity for a self-peptide either to be deleted (to varying degrees) or to undergo selection to become CD4+ CD25+ regulatory T cells. In addition, a high intrinsic affinity of the TCR for a self-peptide appears to be required for thymocytes to undergo selection to become CD4+ CD25+ regulatory T cells. We have also shown that separate populations of HA-specific B cells that participate at distinct phases of the immune response to the HA in BALB/c mice differ significantly in their sensitivity to negative selection by the neo-self HA. Together, these studies demonstrate that both the diversity of the CD4+ T cell and B cell responses to the HA and variations in the expression of the HA in HA Tg mice can significantly affect the mechanisms and extent of CD4+ T and B cell tolerance induction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857965     DOI: 10.1385/IR:27:2-3:161

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  25 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Antigen-induced B-cell death and elimination during germinal-centre immune responses.

Authors:  K M Shokat; C C Goodnow
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

3.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

4.  CD4+ T cells that evade deletion by a self peptide display Th1-biased differentiation.

Authors:  M P Riley; F F Shih; M S Jordan; A L Petrone; D M Cerasoli; P Scott; A J Caton
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

5.  Graded deletion and virus-induced activation of autoreactive CD4+ T cells.

Authors:  M P Riley; D M Cerasoli; M S Jordan; A L Petrone; F F Shih; A J Caton
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

6.  Anergy and suppression regulate CD4(+) T cell responses to a self peptide.

Authors:  M S Jordan; M P Riley; H von Boehmer; A J Caton
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

7.  The diversity of the CD4+ T cell response in influenza.

Authors:  A J Caton; W Gerhard
Journal:  Semin Immunol       Date:  1992-04       Impact factor: 11.130

8.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.

Authors:  J Kirberg; A Baron; S Jakob; A Rolink; K Karjalainen; H von Boehmer
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

9.  Structure-function relationships among highly diverse T cells that recognize a determinant from influenza virus hemagglutinin.

Authors:  A H Taylor; A M Haberman; W Gerhard; A J Caton
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Virus-induced maturation and activation of autoreactive memory B cells.

Authors:  A J Reed; M P Riley; A J Caton
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.